Log in to save to my catalogue

Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants

Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9117141

Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants

About this item

Full title

Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants

Publisher

New York: Nature Publishing Group US

Journal title

Nature medicine, 2022-05, Vol.28 (5), p.1063-1071

Language

English

Formats

Publication information

Publisher

New York: Nature Publishing Group US

More information

Scope and Contents

Contents

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron (B.1.1.529) variant is highly transmissible with potential immune escape. We conducted a test-negative case–control study to evaluate mRNA-1273 vaccine effectiveness (VE) against infection and hospitalization with Omicron or Delta. The large, diverse study population included 26,6...

Alternative Titles

Full title

Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9117141

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9117141

Other Identifiers

ISSN

1078-8956

E-ISSN

1546-170X

DOI

10.1038/s41591-022-01753-y

How to access this item